Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
about
CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquineA randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, PakistanHydroxylated derivatives of NPC1161: theoretical insights into their potential toxicity and the feasibility and regioselectivity of their formationEnantioselective metabolism of primaquine by human CYP2D6.Computational Study on the Effect of Exocyclic Substituents on the Ionization Potential of Primaquine: Insights into the Design of Primaquine-Based Antimalarial Drugs with Less Methemoglobin GenerationSynthesis and evaluation of naphthyridine compounds as antimalarial agentsAn optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in CambodiaDFT study on the radical anions formed by primaquine and its derivatives.Antimalarial and antimicrobial activities of 8-Aminoquinoline-Uracils metal complexes.Triangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapseThe metabolism of primaquine to its active metabolite is dependent on CYP 2D6Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda.Pathway-specific inhibition of primaquine metabolism by chloroquine/quinine.Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to Plasmodium vivax in the Brazilian Amazon Basin.Blocking Plasmodium falciparum Malaria Transmission with Drugs: The Gametocytocidal and Sporontocidal Properties of Current and Prospective Antimalarials.Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry
P2860
Q21034109-F3DE5D73-7EEB-4A10-B0AF-3BDBEFA981D6Q33358051-A6C8CF6D-488D-4AEE-8FC5-3BA2CDD5DC44Q34435707-11A9423E-BAF5-4D22-9FDF-8C0BE5C265BCQ34994945-D6974C57-5E5B-4142-8C41-F8F03F1FF7B2Q35093829-B6B502BB-A389-4973-9CB4-F81A1A0267ADQ36130640-60C3813B-21F3-44A5-83AB-6C765439CB86Q36175374-0238737E-F1E9-40FE-A365-CBEDEDFAC724Q36237258-490A98B0-18A6-4A00-B5D4-899E4B015FC8Q36806815-11419656-C497-44B3-A8F3-B0F05ECAC282Q36898219-D8498E5B-3BF5-4B09-9462-623B69E0771FQ36945581-2C645B26-BF29-4A07-A7AC-54234817C07DQ36952371-B97B9E23-F718-4972-9839-EB362B8F171EQ37251234-9FAE6EF2-19CF-4848-9F32-F84DD443732AQ39413284-EFDF482F-18A6-4A3F-A257-64B12446A5D4Q41912856-D72189F4-E962-4BD4-9064-8AEA9A91B4D7Q47169530-DA26520F-D23F-488B-99EB-D45CC5888227Q56343887-FCDACA5E-9C57-4AA2-A27F-EBCE20567E34
P2860
Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Primaquine-induced hemolytic a ...... hoxy-8-hydroxylaminoquinoline.
@en
Primaquine-induced hemolytic a ...... hoxy-8-hydroxylaminoquinoline.
@nl
type
label
Primaquine-induced hemolytic a ...... hoxy-8-hydroxylaminoquinoline.
@en
Primaquine-induced hemolytic a ...... hoxy-8-hydroxylaminoquinoline.
@nl
prefLabel
Primaquine-induced hemolytic a ...... hoxy-8-hydroxylaminoquinoline.
@en
Primaquine-induced hemolytic a ...... hoxy-8-hydroxylaminoquinoline.
@nl
P2093
P1476
Primaquine-induced hemolytic a ...... thoxy-8-hydroxylaminoquinoline
@en
P2093
Bolchoz LJ
Budinsky RA
McMillan DC
P304
P407
P577
2001-05-01T00:00:00Z